Cancer Foundation Finland Grant Call 2026: Three €600,000 Major Grants, Multi-Year Research Grants and €4,000 Dissertation Grants, Closing 19 August 2026

Cancer Foundation Finland Grant Call 2026: Three €600,000 Major Grants, Multi-Year Research Grants and €4,000 Dissertation Grants, Closing 19 August 2026

Cancer Foundation Finland — Syöpäsäätiö — describes itself as the largest private funder of cancer research in Finland, and its single annual grant call is the moment when that money is distributed. The 2026 call opened on 1 June and closes at 23:59 on Wednesday 19 August 2026. Everything the foundation funds in a given year moves through this one window: three major grants of €600,000 each, research grants running one to three years, and €4,000 dissertation grants for doctoral researchers finishing a cancer-related thesis.

The structure matters more than the headline numbers. This is not a rolling programme with several chances a year, and it is not a targeted call built around a predetermined disease site or technology. It is an open, investigator-driven competition where the foundation asks what the strongest cancer research in Finland is right now and funds it. If you miss 19 August, the next comparable opportunity is roughly twelve months away.

Key Details

What the Three Grant Types Actually Fund

Major grants are the flagship instrument: three awards of €600,000, each covering a three-year research project. They are aimed at senior-level researchers with an established track record and a project substantial enough to absorb €200,000 a year. The foundation describes this funding as non-targeted, meaning it does not prescribe a topic within cancer research — the competition is on scientific quality and relevance, not on fitting a predetermined theme. Payments run in six instalments beginning January 2027, which means a successful applicant should plan for a project genuinely starting in the new year rather than one already halfway through.

Research grants are the broader workhorse category. They are awarded for one, two or three years, and the foundation explicitly prioritises longer funding periods in its decisions. An important practical note: you may be awarded a shorter period than you applied for, but never a longer one. That asymmetry should shape how you build the application. Asking for one year when the science genuinely needs three caps your own ceiling; asking for three when the plan only supports one invites the panel to trim you back or reject the plan as poorly scoped.

Dissertation grants sit at €4,000 and are awarded once per person. They are designed for doctoral researchers in the final stretch of a cancer-related thesis. The eligibility bar is concrete rather than aspirational: you need published articles relevant to the dissertation, or clear evidence that the work has reached an advanced stage. This is finishing money, not starting money.

The foundation also awards travel grants, but those are handled in a separate spring round. For this call, the practical consequence is that research grant recipients are not given separate travel funding — conference attendance, collaboration visits and any other travel must be budgeted inside the application you submit by 19 August. Applicants who leave travel out on the assumption they can request it later end up funding it from money they never asked for.

Who This Fits

The clearest fit is a senior researcher based at a Finnish university, university hospital, or research institute, running a cancer research group and looking for three years of stable core funding. For that person, the major grant is one of the few private awards in Finland at a scale that can carry a group rather than a single project workstream.

The research grant category is wider. It fits principal investigators at any point past early independence who have a defined cancer-relevant project and can articulate a one-to-three-year arc for it. The foundation is explicit that the work must be led from Finland and carried out in Finland; international collaboration is normal in cancer research and is not a problem, but the funded activity itself needs a Finnish home.

Doctoral researchers are served by the dissertation grant, and the honest framing is that €4,000 is a completion supplement rather than a salary. It is worth applying for if you are close to the finish line and it buys you time or covers publication and defence costs.

The fit is poor if you are running a company-based research or product development project — the foundation does not fund these. It is also poor if your connection to cancer is indirect. The foundation asks for a clear connection to cancer, or to cancer prevention, detection, treatment or rehabilitation. Basic biology with a plausible eventual oncology application is a harder sell than work whose cancer relevance is visible in the first paragraph of the research plan.

Eligibility and the Tobacco Restriction

The eligibility rules are short but each one has teeth.

Research must be conducted in Finland. Major and research grants target senior-level researchers. The project needs a demonstrable cancer connection. Company R&D is excluded. A researcher may hold only one Cancer Foundation Finland grant at a time, which means you cannot stack a major grant on top of an active research grant, and you should not submit multiple applications in the same call hoping one lands.

The tobacco industry restriction deserves particular attention because it is unusually explicit and because researchers sometimes assume it only covers direct employment. The foundation excludes applicants funded by the tobacco industry, defining that industry as entities deriving a major share of their income from manufacturing or marketing tobacco products. If any part of your research funding portfolio traces back to such an entity — directly, or through a foundation or research programme that it finances — you need to establish that before you submit, not after a decision. For a cancer research funder this is a matter of institutional identity, not paperwork, and it is not a rule that gets waived.

Dissertation grants add their own condition: published articles relevant to the thesis, or evidence that the work is at an advanced stage, plus the once-per-person limit.

The Application Process, Step by Step

Everything runs through the foundation’s electronic grant application system at syopasaatio.rimbert.fi. There is no paper route and no email submission.

1. Create your account in the application system early. Do not first log in on 19 August. Account setup, institutional details and the structure of the form all take time you will not want to spend on deadline day.
2. Choose the right grant type. Major grant, research grant, or dissertation grant. You submit one application; there is no mechanism to be considered for a second category as a fallback.
3. Write the research plan to the limit. Maximum five pages, minimum 12pt font. The page limit is the binding constraint on how much you can explain, and the font floor exists precisely to stop applicants from compressing ten pages into five.
4. Assemble the publication list. The principal researcher’s publications from 2016–2026, with the five most significant identified and the complete list appended. Choosing those five is a judgement call, not an administrative step — see the preparation section below.
5. Write the application in English, and add the Finnish popular summary. The foundation prefers a popular-language summary in Finnish. This is not decorative: Cancer Foundation Finland is donation-funded, and lay-readable Finnish summaries are how funded research is communicated to the public that paid for it.
6. Attach a clinical trial protocol or synopsis if your project involves one.
7. Submit before 23:59 on 19 August 2026. Applications cannot be supplemented after the deadline. Late applications are rejected, and so are applications that do not follow the instructions.

That last point is stated plainly by the foundation and is worth taking literally. There is no supplementation window, no request for missing attachments, and no discretionary extension. A missing publication list is not a query — it is a rejected application.

Timeline and What Happens After You Submit

• 1 June 2026 — call opens; the application system accepts submissions.
• 19 August 2026, 23:59 — call closes. Hard cut-off.
• Autumn 2026 — scientific review. The foundation assesses scientific quality, feasibility, the applicant’s merits, and cancer relevance.
• December 2026 — awarded grants announced.
• January 2027 — first payment issued; grants are paid in six-month instalments across the funding period.

Two planning consequences follow from this calendar. First, there is a four-month gap between submission and news, so this is not funding that can rescue a project running out of money in October. Second, the money starts flowing in January 2027, so any project timeline you write should begin there. A research plan whose first milestone is dated September 2026 signals that the applicant did not read the payment schedule.

Required Materials Checklist

• Completed application form in the electronic system, in English
• Research plan, maximum five pages, minimum 12pt font
• Principal researcher’s publications 2016–2026, with the five most important highlighted and the full list appended
• Popular summary in Finnish
• Clinical trial protocol or synopsis, where the project includes a clinical trial
• Budget, including any travel and conference costs, with overhead kept at or below 15%

How to Prepare a Competitive Application

Make the cancer relevance unmissable in the first paragraph. The foundation’s stated criteria put relevance to cancer research alongside quality and feasibility. Reviewers reading dozens of applications should not have to reach page three to understand why yours belongs in a cancer funding competition. State the disease connection — prevention, detection, treatment, or rehabilitation — before you state the mechanism.

Treat five pages as a design constraint, not a limitation to fight. The most common failure at this length is a plan that spends three pages on background and two on what will actually be done. Invert that. Reviewers assessing feasibility want to see the experiments, the sample sizes, the cohorts, the access arrangements, and the decision points where the project would change course.

Choose the five highlighted publications strategically. They should demonstrate three things at once: that you publish at a level consistent with the funding you are requesting, that you have relevant technical command of the methods in the plan, and that you finish what you start. A highly cited paper from 2017 in an unrelated area does less for you than a 2024 paper showing you already have the model system working.

Budget the travel you will actually need. Because separate travel grants are not available to research grant recipients, the conference and collaboration travel you omit is travel you will not have. Include it, cost it realistically, and justify it briefly.

Match the requested duration to the science. The foundation prioritises longer periods and will not extend beyond what you ask. If the project is genuinely a three-year arc, request three years and show the year-by-year structure that makes it one.

Write the Finnish summary properly. It is short, but a donation-funded foundation reads it as evidence that you understand who ultimately paid for your grant. A rushed machine translation reads as exactly that.

Common Mistakes

• Submitting on the final evening without a system account. Registration, form navigation and attachment upload all consume time. The 23:59 cut-off is enforced.
• Assuming missing attachments will be requested. They will not. The foundation states that applications cannot be supplemented after the deadline and that non-compliant applications are rejected.
• Leaving travel out of the budget. No separate travel grants for this cohort.
• Applying for a shorter period than the project needs. You can be cut down but never extended.
• Holding, or applying while holding, another Cancer Foundation Finland grant. Only one at a time.
• Submitting a company product-development project in research clothing. Explicitly out of scope.
• Ignoring the tobacco funding rule. Check the provenance of your existing funding before submitting, not after.
• Formatting tricks to beat the page limit. The 12pt minimum exists because applicants have tried it.
• Applying for a dissertation grant too early. Published relevant articles or a demonstrably advanced thesis are the bar.

Frequently Asked Questions

Can I apply from outside Finland? The requirement is that the research is carried out in Finland. The nationality of the applicant is not the gating factor; the location of the funded work is. If you are relocating a group to a Finnish institution, the application needs to make that arrangement concrete.

Can I apply for both a major grant and a research grant? No. A researcher may submit only one application per call and may hold only one Cancer Foundation Finland grant at a time. Choose the category that fits the project’s scale.

How competitive are the major grants? Three are awarded. The foundation does not publish application counts or success rates, so any specific figure would be invention. Treat three national awards for open-topic senior cancer research as a small number and calibrate accordingly.

Is the €600,000 salary, running costs, or both? The foundation does not publish a fixed cost breakdown for major grants; you build the budget for your project. The published constraint is that overhead reimbursement is capped at 15% of the grant.

When exactly does the money arrive? The first payment is in January 2027, with payment in six-month instalments across the funding period.

Can I apply in Finnish? Applications are completed in English. The popular summary is preferred in Finnish.

Is there a separate travel grant round? The foundation awards travel grants in the spring, in a separate process. Recipients of grants from this call do not receive separate travel grants, so budget travel inside this application.

What if my project only becomes cancer-relevant in later stages? That is the weakest position in this competition. The stated criterion is a clear connection to cancer or to its prevention, detection, treatment or rehabilitation. Speculative downstream relevance competes badly against work whose connection is direct.

Next Steps

If you are a senior cancer researcher in Finland and 19 August 2026 is still ahead of you, the sequence is straightforward: open an account at syopasaatio.rimbert.fi today, read the official call guidelines in full, and start with the publication list rather than the research plan — it is the piece most often left to the last hour and the piece that requires the most judgement.

If the deadline has passed by the time you read this, the call runs annually on a similar rhythm — opening in June and closing in mid-to-late August — so the productive move is to note the window now and use the intervening year to build the track record the assessment criteria reward. The foundation also runs a separate travel grant round in the spring, which is worth watching if conference or collaboration funding is your immediate need.

Official Links

• Call guidelines (official): https://syopasaatio.fi/en/research/call-guidelines/
• Major grants: https://syopasaatio.fi/en/research/major-grants/
• Research grants: https://syopasaatio.fi/en/research/research-grants/
• Information for researchers: https://syopasaatio.fi/en/research/for-researchers/
• Electronic application system: https://syopasaatio.rimbert.fi/

Always confirm dates, amounts and conditions against the foundation’s own call guidelines before submitting. Details on this page reflect the 2026 call as published by Cancer Foundation Finland and were checked on 4 August 2026.